Fei Zhou
Beijing, 100029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Si-Wu-Tang attenuates liver fibrosis via regulating lncRNA H19-dependent pathways involving cytoskeleton remodeling and ECM deposition.
Journal: Chinese journal of natural medicines
Published: September 21, 2023
Acteoside ameliorates hepatic ischemia-reperfusion injury via reversing the senescent fate of liver sinusoidal endothelial cells and restoring compromised sinusoidal networks.
Journal: International journal of biological sciences
Published: June 20, 2023
Inhibiting autophagy to boost antitumor immunity with tetramethylpyrazine-loaded and PD-L1-targeting liposomal nanoparticles.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: June 02, 2023
LncRNA H19-EZH2 interaction promotes liver fibrosis via reprogramming H3K27me3 profiles.
Journal: Acta pharmacologica Sinica
Published: April 09, 2023
Chuanxiong Rhizoma extracts prevent cholestatic liver injury by targeting H3K9ac-mediated and cholangiocyte-derived secretory protein PAI-1 and FN.
Journal: Chinese journal of natural medicines
Published: March 17, 2023
Aurantio-obtusin ameliorates obesity by activating PPARα-dependent mitochondrial thermogenesis in brown adipose tissues.
Journal: Acta pharmacologica Sinica
Published: January 22, 2023
A Novel Tri-Functional Liposome Re-Educates "Cold Tumor" and Abrogates Tumor Growth by Synergizing Autophagy Inhibition and PD-L1 Blockade.
Journal: Advanced healthcare materials
Published: October 27, 2022
Cassiae Semen improves non-alcoholic fatty liver disease through autophagy-related pathway.
Journal: Chinese herbal medicines
Published: March 07, 2022
Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways.
Journal: Frontiers in pharmacology
Published: December 01, 2021
Ferulic Acid Ameliorates Hepatic Inflammation and Fibrotic Liver Injury by Inhibiting PTP1B Activity and Subsequent Promoting AMPK Phosphorylation.
Journal: Frontiers in pharmacology
Published: August 07, 2021
Last Updated: 09/26/2026